1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
EV Biologics, Inc.

EV Biologics, Inc.

YECO
EV Biologics, Inc.US flagOther OTC
0.00
USD
- -
- -
2,890.00Market Cap

Income Statement (USD)

APIChatGPT
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
As of date
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
Sales/Revenue/Turnover
42
44
46
43
10
+ Sales & Services Revenue
42
44
46
43
10
- Cost of Revenue
27
28
29
26
8
+ Cost of Goods & Services
27
28
29
26
8
Gross Profit
16
17
17
16
2
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
2
2
4
13
6
+ Selling, General & Admin
2
2
4
13
6
+ Research & Development
- -
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
14
15
13
3
-4
- Non-Operating (Income) Loss
1
1
1
53
3
+ Interest Expense, Net
1
1
1
1
1
+ Interest Expense
1
1
1
1
1
- Interest Income
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
52
3
Pretax Income
13
14
12
-50
-7
- Income Tax Expense (Benefit)
3
3
3
3
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
10
11
9
-53
-7
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
10
11
9
-53
-7
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
10
11
9
-53
-7
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
10
11
9
-53
-7
EBIT
14
15
13
3
-4
EBITDA
15
17
15
5
-3
EBITDA Margin (%)
35.72
37.35
31.6
12.67
-34.11
EBITA
14
15
13
3
-4
Gross Margin (%)
36.95
38.13
36.49
38.64
19.94
Operating Margin (%)
33.23
34.23
27.81
7.47
-41.34
Profit Margin (%)
23.66
24.05
18.77
-124.73
-78.15
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
1
1
2
2
1
Basic Weighted Avg Shares
2
2
2
2
2
Basic EPS, GAAP
4.23
4.5
5.42
-22.3
-3.08
Basic EPS from Cont Ops
4.23
4.5
5.42
-22.3
-3.08
Diluted Weighted Avg Shares
2
2
2
2
2
Diluted EPS, GAAP
4.23
4.5
5.42
-22.3
-3.08
Diluted EPS from Cont Ops
4.23
4.5
5.42
-22.3
-3.08

Balance Sheet (USD)

APIChatGPT
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
As of date
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
Total Current Assets
14
27
27
11
9
+ Cash, Cash Equivalents & STI
6
20
16
3
2
+ Cash & Cash Equivalents
6
20
16
3
2
+ ST Investments
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
7
6
9
6
5
+ Accounts Receivable, Net
4
5
9
6
5
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
4
1
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
1
- -
1
2
2
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
43
43
51
26
24
+ Property, Plant & Equip, Net
11
34
41
7
7
+ Property, Plant & Equip
16
40
49
65
66
- Accumulated Depreciation
4
6
7
58
59
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
31
8
9
18
18
+ Total Intangible Assets
2
2
5
2
2
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
2
2
5
2
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
29
6
5
16
16
Total Assets
57
70
78
36
33
+ Payables & Accruals
3
4
18
13
15
+ Accounts Payable
2
2
2
2
2
+ Accrued Taxes
1
1
1
1
1
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
15
10
11
+ ST Debt
10
9
13
10
10
+ ST Borrowings
9
8
8
6
6
+ ST Finance Leases
1
2
5
4
5
+ Other ST Liabilities
- -
- -
- -
3
4
+ Deferred Revenue
- -
- -
- -
3
4
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
Total Current Liabilities
13
14
31
25
30
+ LT Debt
1
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
+ LT Finance Leases
1
- -
- -
- -
- -
+ Other LT Liabilities
16
18
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
16
18
- -
- -
- -
Total Noncurrent Liabilities
17
18
- -
- -
- -
Total Liabilities
30
32
31
25
30
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
19
19
19
41
41
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
19
19
19
41
41
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
3
13
21
-32
-39
+ Other Equity
5
6
6
3
2
Equity Before Minority Interest
27
38
47
11
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
27
38
47
11
4
Total Liabilities & Equity
57
70
78
36
33
Shares Outstanding
2
2
2
2
2
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
2
2
5
4
5
Net Debt
3
-12
-8
3
4
Net Debt to Equity
12.47
-31.83
-18.22
26.09
100.26
Tangible Common Equity Ratio
44.64
52.45
57.42
26.55
5.3
Current Ratio
1.07
1.96
0.87
0.42
0.3
Cash Conversion Cycle
- -
20.34
40.08
45.55
120.78

Cash Flow Statement (USD)

APIChatGPT
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
As of date
06/30/2013
06/30/2014
06/30/2015
06/30/2016
06/30/2017
+ Net Income
10
11
9
-53
-7
+ Depreciation & Amortization
1
1
2
2
1
+ Non-Cash Items
- -
- -
- -
60
4
+ Stock-Based Compensation
- -
- -
- -
1
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
53
2
+ Other Non-Cash Adj
- -
- -
- -
7
2
+ Chg in Non-Cash Work Cap
- -
- -
-4
4
4
+ (Inc) Dec in Accts Receiv
- -
-1
-4
-1
-1
+ (Inc) Dec in Inventories
1
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
- -
- -
+ Inc (Dec) in Accts Payable
- -
1
1
4
3
+ Inc (Dec) in Other
- -
- -
- -
2
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
11
12
6
13
2
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-14
-1
-2
-37
-2
+ Acq of Fixed Prod Assets
-14
-1
-2
-37
-2
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
12
- -
+ Increase in Capital Stock
- -
- -
- -
12
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
-2
3
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-16
2
-2
-37
-2
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
-2
-2
-1
-2
- -
+ Cash From Debt
11
7
4
4
- -
+ Repayments of Debt
-13
-9
-6
-7
- -
+ Other Financing Activities
8
2
-7
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
6
- -
-8
11
- -
Effect of Foreign Exchange Rates
- -
- -
- -
-1
- -
Net Changes in Cash
1
14
-3
-13
-1
EBITDA
15
17
15
5
-3
EBITDA Margin (%)
35.72
37.35
31.6
12.67
-34.11
Free Cash Flow
-3
11
4
-23
- -
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
-2
12
5
- -
- -
Free Cash Flow to Equity
- -
10
3
-26
- -
Free Cash Flow per Basic Share
-1.16
4.7
2.61
-9.79
-0.16
Price/Free Cash Flow
- -
- -
1.17
0.08
0.35
Cash Flow to Net Income
1.13
1.13
0.71
-0.25
-0.21
Capital Expenditures
-14
-1
-2
-37
-2